Nanosonics Completes A$20 Million On-Market Share Buy-Back

Nanosonics Limited ( (AU:NAN) ) has shared an update.

Nanosonics Limited, an ASX-listed medical technology company specialising in infection prevention products, manages its capital structure through ordinary fully paid shares and periodic share repurchase programs. The business operates in the healthcare sector, targeting hospitals and clinical environments where stringent infection control is critical.

The company has completed an on-market share buy-back, repurchasing 5,546,728 ordinary shares for a total consideration of about A$20 million. This final notification confirms the conclusion of the buy-back program, signalling an active approach to capital management that may improve earnings per share and potentially support the company’s share price for existing investors.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a medical technology company listed on the ASX under the code NAN, focused on infection prevention solutions for healthcare settings. The company issues ordinary fully paid shares and engages in capital management initiatives, including on-market share buy-back programs, as part of its strategy to manage its balance sheet and shareholder returns.

YTD Price Performance: -10.58%

Average Trading Volume: 796,047

Technical Sentiment Signal: Sell

Current Market Cap: A$1.08B

For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.